BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 193223)

  • 1. Herpes simplex virus nuclear nonvirion antigens detected by anticomplement immunofluorescence.
    Tarro G; Giordano GG; Tripodi A; Cerra R; Di Gioia M; Battista A; Smeraglia R
    Tumori; 1976; 62(6):609-14. PubMed ID: 193223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonvirion antigens produced by herpes simplex viruses 1 and 2.
    Tarro G; Sabin AB
    Proc Natl Acad Sci U S A; 1973 Apr; 70(4):1032-6. PubMed ID: 4352219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis and description of procedures used in the study of the relationship of herpes simplex virus "non-virion" antigens to certain cancers.
    Tarro G
    IARC Sci Publ (1971); 1975; (11 Pt 2):291-7. PubMed ID: 191373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Herpes simplex-genitalis virus nonvirion antigens and their implication in certain human cancers: unconfirmed.
    Sabin AB
    Proc Natl Acad Sci U S A; 1974 Aug; 71(8):3248-52. PubMed ID: 4370064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herpes simplex virus tumor-associated antigens in cancer patients.
    Tarro G; Di Gioia M; Cocchiara R; Smeraglia R; Giordano GG; Tripodi A
    Tumori; 1976; 62(6):615-22. PubMed ID: 193224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virus-specific, labile, nonvirion antigen in herpesvirus-infected cells.
    Tarro G; Sabin AB
    Proc Natl Acad Sci U S A; 1970 Mar; 65(3):753-60. PubMed ID: 4317077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of early antigens in nuclei of cells infected with cytomegalovirus or herpes simplex virus type 1 and 2 by anti-complement immunofluorescence, and use of a blocking assay to demonstrate their specificity.
    Giraldo G; Beth E; Hämmerling U; Tarro G; Kourilsky FM
    Int J Cancer; 1977 Jan; 19(1):107-16. PubMed ID: 64461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation of type 2 herpes simplex virus complement-fixing antigen.
    Palmer EL; Martin ML; Warfield DT
    Appl Microbiol; 1971 Nov; 22(5):925-7. PubMed ID: 4332046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement-fixing antigens of herpes simplex virus types 1 and 2: reactivity of capsid, envelope, and soluble antigens.
    Martin ML; Palmer EL; Kissling RE
    Infect Immun; 1972 Feb; 5(2):248-54. PubMed ID: 4117881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Herpes simplex and herpes genitalis viruses in etiology of some human cancers.
    Sabin AB; Tarro G
    Proc Natl Acad Sci U S A; 1973 Nov; 70(11):3225-9. PubMed ID: 4361685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification of herpes simplex virus tumor associated antigen from human kidney carcinoma.
    Cocchiara R; Tarro G; Flaminio G; Di Gioia M; Smeraglia R; Geraci D
    Cancer; 1980 Oct; 46(7):1594-601. PubMed ID: 6251963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological reactivity of antisera prepared against the sodium dodecyl sulfate-treated structural polypeptides of adenovirus-associated virus.
    Johnson FB; Blacklow NR; Hoggan MD
    J Virol; 1972 Jun; 9(6):1017-26. PubMed ID: 4338635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of herpes simplex virus-related antigens in the nuclei and cytoplasm of biochemically transformed cells with peroxidase/anti-peroxidase immunological staining and indirect immunofluorescence.
    Kurchak M; Dubbs DR; Kit S
    Int J Cancer; 1977 Sep; 20(3):371-80. PubMed ID: 71279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody response to the herpes simplex virus type 2 AG-4 antigen in guinea pigs with genital herpes infections.
    Maragos C; Miller A; May JT
    Aust J Exp Biol Med Sci; 1986 Feb; 64 ( Pt 1)():89-95. PubMed ID: 3008691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Virus-induced antigen in cells infected with the herpes simplex virus].
    Kosiakov PN; Posevaia TA; Kosiakova NP; Barinskiĭ IF
    Vopr Virusol; 1980; (3):291-4. PubMed ID: 6159730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of temperature on the development of immunofluorescent elements in herpes simplex virus infected BS-C-1 cells.
    Géder L; Jeney E; Gönczöl E; Lehel F
    Acta Microbiol Acad Sci Hung; 1970; 17(1):77-84. PubMed ID: 4319260
    [No Abstract]   [Full Text] [Related]  

  • 17. Increase in preexisting cellular antigen-combining groups at different times after infection with different viruses.
    Tarro G; Sabin AB
    Proc Natl Acad Sci U S A; 1970 Oct; 67(2):731-7. PubMed ID: 4331719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reaction of antigens isolated from herpes simplex virus-transformed cells with sera of squamous cell carcinoma patients.
    Notter MF; Docherty JJ
    Cancer Res; 1976 Dec; 36(12):4394-401. PubMed ID: 187320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of type-specific antibody to herpes simplex virus type 1 and 2 in human sera by complement-fixation tests.
    Skinner GR; Hartley CH; Whitney JE
    Arch Virol; 1976; 50(4):323-33. PubMed ID: 179502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corneal immune response to Herpes simplex virus antigens.
    Meyers RL; Pettit TH
    J Immunol; 1973 Jun; 110(6):1575-90. PubMed ID: 4351449
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.